← Back

EC Competition - Pharma Sector · EU-wide · 31 Oct 2024 · Enforcement action

Commission fines Teva €462.6 million over misuse of the patent system and disparagement to delay rival multiple sclerosis medicine

Press release 31 October 2024 Commission fines Teva €462.6 million over misuse of the patent system and disparagement to delay rival multiple sclerosis medicine 1 min read